Alpha Emitter Global Market Report 2024

Description

An alpha emitter is a type of radioactive substance that releases alpha particles during radioactive decay. It includes elements, such as uranium, radium, and plutonium, that undergo alpha decay as part of their natural radioactive processes. Alpha emitters play a significant role in medical treatments, especially cancer therapy, and in various technological applications such as smoke detectors and space exploration.

The main types of radionuclide of alpha emitters are radium, actinium, lead, bismuth, and others. Radium is a radioactive element used in medical treatments and diagnostic procedures. The source is natural sources, artificially produced sources, and others, and applications are pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. It is used by various end-users such as hospitals, medical research institutions, and others.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.30 billion in 2024 at a compound annual growth rate (CAGR) of 23.2%. The growth during the historic period can be attributed to the rising incidence of cancer, increasing research investments, government support and funding, a growing aging population, and the expansion of radiotherapy centers.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. The growth during the forecast period can be attributed to rising medical expenditures, an increasing number of patients with cardiac conditions, a growing use of combination therapies, the rising prevalence of targeted alpha therapy, and heightened research and development activities. Key trends expected in this period include advancements in imaging technologies, innovations in products, strategic collaborations, progress in radiopharmaceutical development, and the creation of new alpha-emitting isotopes.

The rising prevalence of cancer is anticipated to drive the growth of the alpha emitter market in the future. Cancer is a disease marked by the uncontrolled proliferation and spread of abnormal cells, which can form tumors and invade nearby tissues. Contributing factors to cancer prevalence include aging populations, environmental exposures, lifestyle changes, and improved detection methods. Alpha emitters are utilized in cancer treatment to target and destroy tumor cells with high precision, while minimizing harm to surrounding healthy tissues. For example, in August 2023, the Australian Institute of Health and Welfare, an Australian government health administration, projected that the number of Americans diagnosed with cancer (excluding basal cell carcinomas and squamous cell carcinomas of the skin) will rise from 151,000 in 2021 to 185,000 by 2030. Consequently, the increasing prevalence of cancer is fueling the growth of the alpha emitter market.

Major companies in the alpha-emitter market are focusing on investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to gain a competitive edge. These radionuclides are radioactive isotopes that emit alpha particles during decay and are created by accelerating charged particles to high energies in a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable as the first in the U.S. dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. The production was made possible by commissioning a 30 MeV cyclotron, designed to accelerate alpha particles for the high-yield production of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. This acquisition allows Bristol-Myers Squibb to enhance its oncology portfolio by integrating innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio, Inc. is a US-based provider specializing in alpha emitters.

Major companies operating in the alpha emitter market are Cardinal Health Inc., Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, Blue Earth Diagnostics Ltd., International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, ARTbio AS, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, Convergent Therapeutics, TAE Life Sciences, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, Fusion Pharmaceuticals Inc.

North America was the largest region in the alpha emitter market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
Companies Mentioned: Cardinal Health Inc.; Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20439

1. Executive Summary

2. Alpha Emitter Market Characteristics

3. Alpha Emitter Market Trends And Strategies

4. Alpha Emitter Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Alpha Emitter Market Size and Growth

5.1. Global Alpha Emitter Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Alpha Emitter Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Alpha Emitter Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Alpha Emitter Market Segmentation

6.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Radium
Actinium
Lead
Bismuth
Other Types Of Radionuclides
6.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Natural Sources
Artificially Produced Sources
Other Sources
6.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pancreatic Cancer
Ovarian Cancer
Prostate Cancer
Lymphoma
Melanoma
Bone Metastasis
Other Applications
6.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Medical Research Institutions
Other End-Users

7. Alpha Emitter Market Regional And Country Analysis

7.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Alpha Emitter Market

8.1. Asia-Pacific Alpha Emitter Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Alpha Emitter Market

9.1. China Alpha Emitter Market Overview
9.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Alpha Emitter Market

10.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Alpha Emitter Market

11.1. Japan Alpha Emitter Market Overview
11.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Alpha Emitter Market

12.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Alpha Emitter Market

13.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Alpha Emitter Market

14.1. South Korea Alpha Emitter Market Overview
14.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Alpha Emitter Market

15.1. Western Europe Alpha Emitter Market Overview
15.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Alpha Emitter Market

16.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Alpha Emitter Market

17.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Alpha Emitter Market

18.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Alpha Emitter Market

19.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Alpha Emitter Market

20.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Alpha Emitter Market

21.1. Eastern Europe Alpha Emitter Market Overview
21.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Alpha Emitter Market

22.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Alpha Emitter Market

23.1. North America Alpha Emitter Market Overview
23.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Alpha Emitter Market

24.1. USA Alpha Emitter Market Overview
24.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Alpha Emitter Market

25.1. Canada Alpha Emitter Market Overview
25.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Alpha Emitter Market

26.1. South America Alpha Emitter Market Overview
26.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Alpha Emitter Market

27.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Alpha Emitter Market

28.1. Middle East Alpha Emitter Market Overview
28.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Alpha Emitter Market

29.1. Africa Alpha Emitter Market Overview
29.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Alpha Emitter Market Competitive Landscape And Company Profiles

30.1. Alpha Emitter Market Competitive Landscape
30.2. Alpha Emitter Market Company Profiles
- 30.2.1. Cardinal Health Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Lantheus Holdings Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Curium Pharma
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eckert & Ziegler BEBIG GmbH
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Alpha Emitter Market Other Major And Innovative Companies

31.1. Telix Pharmaceuticals Limited
31.2. NorthStar Medical Radioisotopes LLC
31.3. ITM Isotope Technologies Munich SE
31.4. Blue Earth Diagnostics Ltd.
31.5. International Isotopes Inc.
31.6. IBA Radiopharma Solutions
31.7. Orano Med LLC
31.8. ARTbio AS
31.9. Actinium Pharmaceuticals Inc.
31.10. Clarity Pharmaceuticals Ltd.
31.11. RadioMedix Inc.
31.12. Nordic Nanovector ASA
31.13. Convergent Therapeutics
31.14. TAE Life Sciences
31.15. ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

32. Global Alpha Emitter Market Competitive Benchmarking

33. Global Alpha Emitter Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Alpha Emitter Market

35. Alpha Emitter Market Future Outlook and Potential Analysis

35.1 Alpha Emitter Market In 2028 - Countries Offering Most New Opportunities
35.2 Alpha Emitter Market In 2028 - Segments Offering Most New Opportunities
35.3 Alpha Emitter Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer